Trial Profile
Assessing the Safety of Inhaled Zanamivir Exposure in Pregnant Women
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Zanamivir (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 18 Apr 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 22 Feb 2013 Planned number of patients 1 added as reported by ClinicalTrials.gov.
- 02 Nov 2011 New trial record